Ai-Media Technologies Ltd (AIM)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 0.225 |
|---|---|
| 52-week range | 0.185 – 0.925 |
| Return, 1 month / 3 months | −6.2% / +9.8% |
| Return, 1 year / 3 years | −74.0% / −23.7% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 81.9% |
| Worst drawdown (1 year) | -78.3% |
| Average daily value traded | 0.09M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ai-Media Technologies is an Australian company based in Sydney that provides captioning, transcription and translation services. It supplies live and recorded accessibility tools to broadcasters, enterprises, government bodies and educational institutions, helping them make audio and video content accessible and multilingual. Its offerings combine software platforms with human captioners, covering areas such as live broadcast captioning, speech-to-text and language translation for organisations that need accurate text alongside spoken content.
The shares are listed on the Australian Securities Exchange in Australia under the code AIM, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ai-Media Technologies Ltd (AIM) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.225 on 20 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 1,225 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 74.0% and over the last three months it rose 9.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.7% | ||
| From 52-week high | -75.0% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 9.8% | ||
| 6-month return | -8.2% | ||
| 12-month return, skipping the last month | -72.3% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 81.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -78.3% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.09M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.3% |
|---|---|
| 1 month | −6.2% |
| 3 months | +9.8% |
| 6 months | −8.2% |
| 1 year | −74.0% |
| 3 years | −23.7% |
| 5 years | −79.4% |
Signals
| 50-day / 200-day average | 0.236 / 0.295 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.016 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.